Advanced Immune Health for the Global Market
Measurement and management of immune health for superior health outcomes.
Driven by AI, leading science and extensive global data we aim to
deliver novel screening and risk scoring techniques to the global marketplace.
AI Driven Advanced Immune Health for the Global Market
Our mission is to offer tests that are driven by proprietary AI that can identify early immune related risks, help prevent disease and assist in slowing biological aging.
Immunidex™ is pioneering its technology through a combination of leading immunology based science, extensive
cohort data and world class validation.
Working to keep you healthy through the early detection of disease and health vulnerability reducing cost, pain and difficulties associated with symptomatic disease.
Immunidex™ is an innovative AI platform assesses your immune system, drawing on a broad panel of the latest clinical biomarkers.
Immunidex™ to provide preventative medical solutions in a modern world faced with increasingly diversified biological and clinical threats to human health.
Driven by AI, leading science and extensive global data we aim to deliver novel screening and risk scoring techniques to the global marketplace.
Validated and improved by global network of data and AI.
Innovations that are affordable and can be accessed by not just developed countries but emerging markets such as India.
Reduce costs, pain and difficulty associated with post-symptomatic healthcare.
ImmunIdex’s innovative AI platform assesses your immune system, drawing on a broad panel of the latest clinical biomarkers.
Provide the patient an accurate profile of potential vulnerabilities to disease and illness, including the latest strains of viruses such as COVID-19.
Our network of expert clinical partners, AI professionals, scientists and global medical databases helps provide a tailored profile of health needs and immunity information, previously unavailable from locally based, or state-provided healthcare.
To create ‘gold standard testing’ for the measurement and management of immune health for superior health outcomes. Driven by AI, leading science and extensive global data we aim to deliver novel screening and risk scoring techniques to the global marketplace.
Due to the current pandemic immune health is now a priority and consequently we have set to create new innovations that are affordable and can be accessed by not just developed countries but emerging markets such as India.
Our mission is to offer tests that are driven by proprietary AI that can identify early immune related risks, help prevent disease and assist in slowing biological aging. Immunidex™ is pioneering its technology through a combination of leading immunology based science, extensive cohort data and world class validation. This will enable clinically verified assessments of patients well being and underlying immune health.
Our autonomous technology application enables anyone to get in depth information on their immune health and information on how to improve it. My Immune ID assists people to obtain valuable insight into health risks, tests that they can request from their doctor to potentially obtain early diagnosis of health risks and disease.
Adrian is a up and coming clinician who specialises in developing novel blood diagnostics to combat chronic disease. His vision is to develop a series of AI driven and cost-effective approaches that can transform early disease detection including simplifying testing techniques that can assist an overloaded global healthcare system.
He has worked as an associate in dementia research under multiple global leaders from some of the world’s premier institutions, including Sweden’s Karolinska Institute, The University of Melbourne, and the National University of Singapore.
25 years of experience in investing and developing data mining, healthcare and biotechnology start-ups in Europe and Asia.
He currently resides as Chairman of Immunidex and sits on the board of multiple companies focusing on breakthroughs in healthcare and AI.
Paul is a highly experienced software engineer extensive conceptualising, designing, and implementing Distributed Ledger Technology (DLT) and related blockchain technologies. Paul’s experience comprises of multiple senior development roles including IBM where his focus was the development of Hyperledger Fabric.
He has built projects for big enterprises, including: Hyperledger Fabric Proof of Concept (PoC) application.
PhD student in the field of computer science at AGH University of Science and Technology in Cracow. His interests revolve around Artificial Intelligence and Robotics, in particular, input data processing for scene understanding. He is actively working on research projects that involve Deep Learning, Neuroevolution and Reinforcement Learning.
Healthcare provided at the earliest possible stage before any cost, pain or difficulty is accumulated.
